SCHEMBL21031063

SCHEMBL21031063

COc1nc(OC)c(C(C)C)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
PDCD1LG2 Q9BQ51 7/20 0.36
CD274 Q9NZQ7 7/20 0.36
P2RX3 P56373 3/20 0.36
P2RX2 Q9UBL9 3/20 0.36
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HRH4 Q9H3N8 1/20 0.32
THRB P10828 1/20 0.31
RORC P51449 1/20 0.31
CRHR1 P34998 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519307 0.80 TDP1 (0.44) LMNAMEN1KMT2ATDP1HRH4
SCHEMBL23032582 0.77 HRH4 (0.32) LMNAPDCD1LG2CD274P2RX3P2RX2
SCHEMBL21030417 0.77 MALT1 (0.33) LMNAPDCD1LG2CD274P2RX3P2RX2
SCHEMBL25010766 0.76 P2RX3 (0.36) PDCD1LG2CD274P2RX3P2RX2POLB
SCHEMBL21735710 0.74 P2RX3 (0.42) P2RX3P2RX2TRPV1GAA
SCHEMBL20755240 0.73 GLP1R (0.33) LMNACD274MEN1KMT2ATDP1
SCHEMBL21031065 0.72 ADORA2A (0.37) LMNAPDCD1LG2CD274MEN1KMT2A
SCHEMBL21030412 0.72 NOTUM (0.40)
SCHEMBL19237081 0.72 CD274 (0.46) LMNAPDCD1LG2CD274MEN1KMT2A
SCHEMBL31523455 0.72 CD274 (0.46) LMNAPDCD1LG2CD274MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2021-02-25 US disclosed
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO LMNA 4835/4885PDCD1LG2 1288/4885CD274 289/4885
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO LMNA 4835/4885PDCD1LG2 1288/4885CD274 289/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO LMNA 4835/4885PDCD1LG2 1288/4885CD274 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.